Keyword Suggestion
Domain Informations
Alprolix.com lookup results from whois.corporatedomains.com server:
- Domain created: 2011-08-31T18:50:16Z
- Domain updated: 2024-08-27T05:23:13Z
- Domain expires: 2025-08-31T18:50:16Z 0 Years, 296 Days left
- Website age: 13 Years, 69 Days
- Registrar Domain ID: 1674759532_DOMAIN_COM-VRSN
- Registrar Url: http://cscdbs.com
- Registrar WHOIS Server: whois.corporatedomains.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 8887802723
- Name server:
- NS1.SANOFI-SYNTHELABO.COM
- NS2.SANOFI-SYNTHELABO.COM
- NS3.SANOFI-SYNTHELABO.COM
- NS4.SANOFI-SYNTHELABO.COM
Network
- inetnum : 54.247.0.0 - 54.247.255.255
- name : AMAZON-DUB
- handle : NET-54-247-0-0-1
- status : Reallocated
- created : 2014-07-18
- changed : 2014-07-18
Owner
- organization : Amazon Data Services Ireland Limited
- handle : ADSIL-1
- address : Array,Dublin,D24,IE
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 286730 |
namecheap.com | 101387 |
networksolutions.com | 69118 |
tucows.com | 52617 |
publicdomainregistry.com | 39120 |
whois.godaddy.com | 32793 |
enomdomains.com | 23825 |
namesilo.com | 21429 |
domains.google.com | 21384 |
cloudflare.com | 20573 |
gmo.jp | 18110 |
name.com | 17601 |
fastdomain.com | 14708 |
register.com | 13495 |
net.cn | 12481 |
ionos.com | 12416 |
ovh.com | 12416 |
gandi.net | 12305 |
registrar.amazon.com | 12111 |
Host Informations
- IP address: 54.247.151.159
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
Site Inspections
Port Scanner (IP: 54.247.151.159)
Spam Check (IP: 54.247.151.159)
Recent Searched Sites
› Alprolix.com (0 seconds ago) / IE
› Aptiv.com (1 seconds ago) / US
› Upssupplychainsolutions.com (12 seconds ago) / US
› Bageshwardham.net (3 seconds ago) / US
› Tripack.theonlinecatalog.com (22 seconds ago) / US
› Stemundergrads.science.gov (13 seconds ago) / US
› Mythx.io (2 seconds ago) / US
› Kantarmetaskope.com (12 seconds ago) / DE
› Ocwen.com (3 seconds ago) / US
› Air-corporate.com (3 seconds ago) / US
› Resyos.com (0 seconds ago) / US
› Pepsilipton.com (3 seconds ago) / US
› Stenaline.se (1 seconds ago) / US
› Ask-books.com (29 seconds ago) / JP
› Bibliavida.com (17 seconds ago) / US
› Extracteur-donnees-mag-yr.com (10 seconds ago) / US
› Myprimerica.com (8 seconds ago) / US
› Collectauctions.net (4 seconds ago) / US
› Connect.filae.com (1 seconds ago) / US
› Dywidag.com (24 seconds ago) / US
Websites Listing
We found Websites Listing below when search with alprolix.com on Search Engine
ALPROLIX® [Coagulation Factor IX (Recombinant), Fc Fusion ...
Want to learn more about alprolix? We'd like to send you helpful information on hemophilia B and ALPROLIX from time to time. If you're still considering ALPROLIX we'll send you a Bluetooth ® speaker to listen to patient stories or if you're already on ALPROLIX, a cooler bag.. Email
Alprolix.comALPROLIX | FDA
October 19, 2017 Summary Basis for Regulatory Action - ALPROLIX November 3, 2017 Approval Letter - ALPROLIX Approval History, Letters, Reviews, and Related Documents - ALPROLIX
Fda.govALPROLIX® | Alprolix instructions
2021-04-14 · If you have any questions, requests or complaints about how we process your personal information, simply write to us using the email address: [email protected]. If you have any comments or complaints regarding the way your personal data is being handled, you have the right to contact the supervisory authority in Sweden (Swedish: Datainspektionen, see this link ) …
Alprolix-instructions.comALPROLIX - Medsafe
ALPROLIX ® Eftrenonacog alfa (recombinant coagulation factor IX fusion protein) 250, 500, 1000, 2000, 3000, 4000 ... Email: [email protected] . ALPROLIX is supplied in New Zealand by: Sanofi-aventis New Zealand limited . Level 8, 56 Cawley Street . Ellerslie, Auckland . New Zealand Free Call: 0800 283 684 . Email: [email protected] . This leaflet …
Medsafe.govt.nzALPROLIX - saskatoonhealthregion.ca
Saskatoon Health Region is part of the provincial Saskatchewan Health Authority. Font Size: A A A
Saskatoonhealthregion.caAlprolix® - Sobi Deutschland
ALPROLIX ist ein Arzneimittel zur Behandlung und Vorbeugung von Blutungen bei Patienten aller Altersklassen mit Hämophilie B (erbliche Blutungsstörungen aufgrund eines Faktor IX-Mangels). ALPROLIX wird mittels eines rekombinanten Verfahrens hergestellt, bei dem keine Materialien menschlichen oder tierischen Ursprungs zugesetzt werden. Wie ALPROLIX wirkt. Bei …
Sobi-deutschland.deALPROLIX® | Alprolix instructions
Sobi may, when it is necessary for the purposes of Sobi’s legitimate interest in order to enable users to access the website, collect, use and store different kinds of personally identifiable information such as names, internet protocol (IP) addresses, email addresses and other technology on the devices used to access the website. Sobi will only use the user’s personal …
Alprolix-instructions.comAlprolix for Hemophilia B - Hemophilia News Today
2020-03-05 · Alprolix is an approved recombinant DNA-derived coagulation factor IX concentrate for people with hemophilia B. Biogen initially developed Alprolix and spun off Bioverativ Therapeutics to further develop the therapy. Sanofi then acquired Bioverativ.. Alprolix is used as an on-demand treatment to control bleeding episodes, for the management of bleeding during …
Hemophilianewstoday.comRealPatients - ALPROLIX® Pro
2014-03-28 · ALPROLIX is contraindicated in patients who have a known history of hypersensitivity reactions, including anaphylaxis, to the product or its excipients. WARNINGS AND PRECAUTIONS: Allergic-type hypersensitivity reactions, including anaphylaxis, are possible with factor replacement therapies, and have been reported with ALPROLIX. Discontinue use …
Alprolixpro.comAlprolix - Fachinformation - iMedikament.de
Alprolix ist als Pulver und Lösungsmittel erhältlich, die zur Herstellung einer intravenösen Injektionslösung miteinander vermischt werden. Dosis und Häufigkeit der Behandlung sind vom Körpergewicht des Patienten und davon abhängig, ob Alprolix zur Behandlung oder zur Vorbeugung einer Blutung angewendet wird, und richten sich nach dem Schweregrad des …
Imedikament.deAlprolix: Scheda Tecnica e Prescrivibilità - Torrinomedica
2021-06-18 · ALPROLIX 3.000 UI polvere e solvente per soluzione iniettabile. Ogni flaconcino contiene nominalmente 3000 UI di fattore IX della coagulazione umano (rDNA), eftrenonacog alfa. ALPROLIX contiene approssimativamente 3000 UI (600 UI/mL) di fattore IX della coagulazione umano (rDNA), eftrenonacog alfa, dopo la ricostituzione.
Torrinomedica.itFachinformation - Sobi Deutschland
Tabelle 1: Richtlinie für die Dosierung von ALPROLIX bei der Behandlung von Blutungsepisoden und chirurgischen Eingriffen. 3 ALPROLIX Fachinformation koagulopathie festzustellen. In den genannten Fällen muss der Nutzen einer Behandlung mit ALPROLIX gegen die Risiken dieser Komplikationen abgewogen werden. Kardiovaskuläre Ereignisse Bei Patienten mit …
Sobi-deutschland.deDailyMed - ALPROLIX (coagulation factor ix- recombinant ...
ALPROLIX ® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Routine prophylaxis to reduce the frequency of bleeding episodes. For intravenous use after reconstitution only. Repeat every 48 hours as needed if there is further evidence of bleeding.
Dailymed.nlm.nih.govANEKS I CHARAKTERYSTYKA PRODUKTU LECZNICZEGO
ALPROLIX zawiera około 3000 IU (600 IU/ml) ludzkiego czynnika krzepnięcia IX (rDNA), eftrenonakogu alfa po rekonstytucji. Aktywność (wyrażona w IU) oznaczana jest za pomocą jednostopniowego testu krzepnięcia. Swoista aktywność produktu ALPROLIX wynosi 55-84 IU/mg białka. 3 . Eftrenonakog alfa (rekombinowany ludzki czynnik krzepnięcia IX, białko …
Ema.europa.euALPROLIX 1000 UI pdre/solv p sol inj - VIDAL
2021-07-06 · Grossesse et allaitement : Alprolix n'a fait l'objet d'aucune étude sur les fonctions de reproduction chez l'animal. Une étude sur le passage transplacentaire a été effectuée chez la souris (cf Sécurité préclinique).En raison de la rareté de l'hémophilie B chez la femme, il n'y a pas de donnée disponible sur l'utilisation de facteur IX lors de la grossesse ou de l'allaitement.
Vidal.frChild With Inhibitors Against Alprolix Returns to Therapy ...
2021-10-22 · The first documented case of a previously untreated hemophilia B patient developing inhibitors against the extended half-life therapy Alprolix was described in a report from Canada.. The report also shows how combining routine administration of Alprolix with medications that suppress the immune system can be used to stop the production of inhibitors.
Hemophilianewstoday.comHealth Canada Approves Marketing License Transfer for ...
2017-07-10 · ALPROLIX is approved and marketed by Bioverativ for the treatment of hemophilia B in the United States, Japan, and Canada. ... (781) 663 …
Newswire.caALPROLIX, INN-eftrenonacog alfa - Europa
Alprolix hat sich in 2 Hauptstudien, an denen Patienten mit Hämophilie B teilnahmen, zur Vorbeugung und Behandlung von Blutungsepisoden als wirksam erwiesen. In der ersten Studie, an der 123 Erwachsene und Jugendliche ab einem Alter von 12 Jahren teilnahmen, wiesen Patienten, die Alprolix als wöchentliche Behandlung zur Vorbeugung erhielten, rund 3 …
Ema.europa.eu
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
themetapicture.com | godaddy.com | -2 Years, -256 Days |
painwoman.com | namecheap.com | -2 Years, -94 Days |
ispor-jp.org | jprs.jp | -1 Years, -286 Days |
screely.com | namecheap.com | -2 Years, -187 Days |
sampleplanners.com | godaddy.com | -1 Years, -127 Days |
kyammc.com | godaddy.com | -1 Years, -324 Days |
orthodoxcouncil.org | enom.com | -2 Years, -124 Days |
mydebrid.com | regtons.com | -2 Years, -241 Days |
junip.co | namecheap.com | -2 Years, -257 Days |
systemweakness.com | namecheap.com | -2 Years, -219 Days |